Company intelligence / Profile preview

TTP Group

Austria

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

TTP Group delivers engineering and consulting services covering the full lifecycle of biotech and pharma facility development for blue-chip clients in Europe; recent projects include state-of-the-art facilities for mRNA technology and new supply chain/manufacturing capabilities.

Industry: Consulting

Partnerships

Blue-chip biotech and pharma clients across EuropeFinancial investor: Robus Capital (former minority investor)

Beyond the preview

Go deeper on TTP Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TTP Group.

Explore the full profile